دورية أكاديمية
Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial
| العنوان: | Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial |
|---|---|
| المؤلفون: | Liu, Lun-FeiAff1, Aff2, Chen, Ji-Su, Gu, Jun, Xu, Jin-Hua, Jin, Hong-Zhong, Pang, Xiao-Wen, Wang, Gang, Yu, Chen, Song, Zhi-Qiang, Guo, Zai-Pei, Li, Wei, Lai, Wei, Cui, Pan-Gen, Chen, Min, Fang, Hong, Lyu, Cheng-Zhi, Li, Yu-Zhen, Sun, Qing, Xie, Hong-Fu, Liu, Xiao-Ming, Gao, Xing-Hua, Shi, Yu-Ling, Zhao, Nai-Qing, Zhang, Wei, Zheng, MinAff1 |
| المصدر: | Archives of Dermatological Research: Founded in 1869 as Archiv für Dermatologie und Syphilis. 312(6):437-445 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 03403696 1432069X |
|---|---|
| DOI: | 10.1007/s00403-019-02024-6 |